Treatment of renal tumors with VTP in combination with systemic PD1/PDL1 pathway inhibition resulted in tumor regression, prolonged survival, and decreased lung metastasis development, which was associated with an increased ratio of CD8+: regulatory T cells and increased T cell infiltration at sites of lung metastases.22 The gene discussed is CD8A; the disease is neoplasm.